TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
JMVA Biotech AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
1,367
|
1,290
|
1,292 |
Financial expenses |
0
![]() |
0
![]() |
0 |
Earnings before taxes |
739
|
362
|
219 |
EBITDA |
707
|
359
|
219 |
Total assets |
2,222
|
2,191
|
2,386 |
Current assets |
2,222
|
2,191
|
2,386 |
Current liabilities |
24
|
15
|
195 |
Equity capital |
2,140
|
2,110
|
2,125 |
- share capital |
50
![]() |
50
![]() |
50 |
Employees (average) |
1
![]() |
1
![]() |
1 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
96.3%
![]() |
96.3%
|
89.1% |
Turnover per employee |
1,367
|
1,290
|
1,292 |
Profit as a percentage of turnover |
54.1%
|
28.1%
|
17.0% |
Return on assets (ROA) |
33.3%
|
16.5%
|
9.2% |
Current ratio |
9258.3%
|
14606.7%
|
1223.6% |
Return on equity (ROE) |
34.5%
|
17.2%
|
10.3% |
Change turnover |
77
|
-2
|
-594 |
Change turnover % |
6%
|
0%
|
-31% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.